OS Therapies (OSTX) Stock: Buy, Sell, or Hold?
OSTX - OS Therapies Incorporated
$1.25
0.00 (0.00%)
▲
5d:
-5.3%
30d:
-24.7%
90d:
-18.3%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 13, 2026
19d
Get Alerted When OSTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: OSTX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: OSTX shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.23
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1.39
9.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 4.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OSTX is currently trading at $1.25, which is considered oversold relative to its 30-day fair value range of $1.47 to $1.76. From a valuation perspective, the stock is trading at a discount (Forward PE: 3.6) compared to its historical average (4.6). Remarkably, the market is currently pricing in an annual earnings decline of 7.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OSTX is in a uptrend. The price is currently testing key support at $1.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OSTX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.50 (+580.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OSTX is in a uptrend. The price is currently testing key support at $1.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OSTX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.50 (+580.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.47 -
$1.76
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
90.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 580.0% below Wall St target ($8.50)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.47 -
$1.76
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.23
Resistance Level
$1.62
Current Trend
Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.61
Wall Street Target
$8.50
(+580.0%)
Valuation Discount vs History
-7.7% cheaper
PE vs Historical
3.6 vs 4.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.7%
(market-implied from PE analysis)
1-Year Target
$1.15
(-8%)
2-Year Target
$1.06
(-15%)
3-Year Target
$0.98
(-21%)
3-Yr Target (if PE normalizes)
(PE: 4→5)
$1.25
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.6 to 4.6
Stabilization Target:
$1.59
(+27.6%)
PE Expansion Potential:
+27.6%
Share & Embed Analysis
Last updated: October 24, 2026 4:49 PM ET
Data refreshes hourly during market hours. Next update: 5:49 PM
Data refreshes hourly during market hours. Next update: 5:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$571 | 58 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$369 | 52 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
27 analysts |
$436 | 38 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$307 | 51 HOLD |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
18 analysts |
$144 | 75 BUY |
